Alex Sirois

Alex Sirois

InvestorPlace Contributor

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

Novavax Takes Monumental Step Forward, Becomes Worthy

By Alex Sirois, InvestorPlace Contributor

NVAX stock has disappointed as application delays have stunted its promise. That has changed, and so has its investment worthiness.

Progenity Offers Nothing That Dozens of Other Biotechs Don’t

By Alex Sirois, InvestorPlace Contributor

PROG stock should suffer dilution but its IP strength will lure some in nonetheless. It looks like a biotech to avoid.

Dogecoin May ‘Sit’ for a While Thanks to Shiba Inu and Market Pressure

By Alex Sirois, InvestorPlace Contributor

Dogecoin has competition in the form of the other dog inspired cryptocurrency of note. But Bitcoin is also exerting downward pressure.

ProShares Big Data Refiners ETF Attempts to Make Sense of the Numbers

By Alex Sirois, InvestorPlace Contributor

ProShares Big Data Refiners ETF targets one of the fastest growing industries, with projected CAGR of 10% over the next five years.

Why I Wouldn’t Buy Skillz’s Stock Before Earnings Next Week

By Alex Sirois, InvestorPlace Contributor

Investors should wait to see whether the company can get its losses in check before taking a position in SKLZ stock.

Load More